« Back to Record
Harding, J. J., Awada, A., Roth, G., Decaens, T., Merle, P., Kotecki, N., Dreyer, C., Ansaldi, C., Rachid, M., Mezouar, S., Menut, A., Bestion, E. N., Paradis, V., Halfon, P., Abou-Alfa, G. K., & Raymond, É. E. (2022). First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers. Liver Cancer, 11(3), 268-277. doi:10.1159/000522418
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/345909



